

Hezen Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 0.50 M
- Company Age 20 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.10 Cr
- Revenue Growth %
- Ebitda
- Net Worth -0.63%
- Total Assets %
About Hezen Pharmaceuticals
Hezen Pharmaceuticals Limited (HPL) is a Public Limited Indian Non-Government Company incorporated in India on 27 July 2004 and has a history of 20 years and eight months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Hezen Pharmaceuticals Private Limited. The Company is engaged in the Infrastructure And Utilities Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹10.10 Cr.
Raghuveer Acharya, Venkat Kudimuskula, and Prasad Kudimuskula serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24239TG2004PLC043758
- Company No.
043758
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 Jul 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Hezen Pharmaceuticals?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Raghuveer Acharya ![]() | Director | 25-May-2006 | Current |
Venkat Kudimuskula ![]() | Director | 27-Jul-2004 | Current |
Prasad Kudimuskula ![]() | Director | 27-Jul-2004 | Current |
Financial Performance of Hezen Pharmaceuticals.
Hezen Pharmaceuticals Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.63%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth |
| ||||||
EBITDA |
What is the Ownership and Shareholding Structure of Hezen Pharmaceuticals?
In 2023, Hezen Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Octans Nutra Private Limited
Venkat Kudimuskula and Prasad Kudimuskula are mutual person
- Titlesuit Solutions Private Limited
Prasad Kudimuskula is a mutual person
Charges (Loans)
₹10.10 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of Hyderabad : 6.50 Cr
- Syndicate Bank : 3.60 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
02 Jan 2006 | State Bank Of Hyderabad | ₹6.50 Cr | Open |
12 Aug 2005 | Syndicate Bank | ₹1.00 M | Open |
01 Jul 2005 | Syndicate Bank | ₹3.50 Cr | Open |
How Many Employees Work at Hezen Pharmaceuticals?
Unlock and access historical data on people associated with Hezen Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Hezen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hezen Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Hezen Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Hezen Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Hezen Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
- Director Appointment
Raghuveer Laxminarayan Govinda Acharya was appointed as a Director was appointed as a Director on 25 May 2006 & has been associated with this company since 18 years 10 months .
- Charges
A charge with State Bank Of Hyderabad amounted to Rs. 6.50 Cr with Charge ID 90263015 was registered on 02 Jan 2006.
- Charges
A charge with State Bank Of Hyderabad of Rs. 6.50 Cr registered on 02 Jan 2006 with Charge ID 90263015 was modified on 02 Jan 2006.
- Charges
A charge with Syndicate Bank amounted to Rs. 0.10 Cr with Charge ID 90262765 was registered on 12 Aug 2005.
Frequently asked questions
What is the Incorporation or founding date of Hezen Pharmaceuticals Limited?
Hezen Pharmaceuticals Limited was incorporated on 27 Jul 2004.
What is authorized share capital and paid-up capital of Hezen Pharmaceuticals Limited?
The authorized share capital of Hezen Pharmaceuticals Limited is ₹ 2.00 Cr and paid-up capital is ₹ 0.50 M.
Who are the current board members & directors of Hezen Pharmaceuticals Limited?
Currently 3 directors are associated with Hezen Pharmaceuticals Limited.
- Raghuveer Laxminarayan Govinda Acharya
- Venkat Reddy Kudimuskula
- Prasad Reddy Kudimuskula
What is the registered address of Hezen Pharmaceuticals Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Hezen Pharmaceuticals Limited is D.No.19-79/23 Plot No.23Balaji Enclave Uppal, Hyderabad, Telangana, India, 500039.
What is the corporate identification number (CIN) and company number of Hezen Pharmaceuticals Limited?
The corporate identification number (CIN) of Hezen Pharmaceuticals Limited is U24239TG2004PLC043758 and the company number is 043758 as per Ministry of Corporate Affairs (MCA).
What is the official website of Hezen Pharmaceuticals Limited?
The Official website of Hezen Pharmaceuticals Limited is https://www.hezen25.bloombiz.com
What change has been observed in the net worth of Hezen Pharmaceuticals Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Hezen Pharmaceuticals Limited has experienced an downturn of -0.63%.
What are the total open charges for Hezen Pharmaceuticals Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Hezen Pharmaceuticals Limited amount to ₹ 10.10 Cr.
When was the last Balance Sheet of Hezen Pharmaceuticals Limited filed with the ROC?
The most recent Balance Sheet for Hezen Pharmaceuticals Limited was filed with the ROC on 31 Mar 2023.